Intas Pharma
Intas Pharma
an a
.
LNG INDIA
. "
INDIANONJUDICIAL
JERLd TuTA GUJARAT
CEUT
3I(INTAS)
651
A
4 H M EA
D BAD
Li-Ri.l/ 14-*1Clec
.. dst
ameeaeragoo**
AGREEMENT
This agreement for
plasma supply (hereinafter referred to as "reement") entered on this 18th Day Of
August 2017 by and between:
Dr Vasantrao Pawar Medical College, Hospital & Researclh Ceater ( Blood Bank) a
Trusted duly
registered and validly existing under the provisions of the Companies Act, 1956, having its registered office at
Mumbai-Agra National Hwy, Vasantdadanagar, Adgaon, Nashik -422207 Maharashtra .India,
reinafter referred to as "Dr Vasantrao Pawar Medical College, Hospital & Resenrch Center ( Blood
PDWhich expression shall mean and include its successors in business and pernited assigns) of the
FIRST PART.
AND
INTAS PHARMACEUTICALS LTD. a company duly registerod rnd validly cxisting under the provisions
orthe Companies Act, 1956, having its registered office at Corp:ite House, S.G. Highway, Thaltej,
Near' Sola Bridge, Ahmedabad- 380054, Gujarat, ndie,iereinafter referred to as IPL which
CApression shall mean and include its successors in business and per:. itted assigns) of the SEcOND PART.
Page 1 of9
cANTRAOPAWAR MEDICAL COLLEGE, HOSPITAL &
ANKand IPL are heremajter naividually or collectively referred to as RESEARCH CENTER ( BL0OD
the "Party" or the
"Parties"
WHEREAS
1.
Definitions &Interpretation
a) As used in this Agreement, the following terms shall mean aid be interpreted to convey the meanings
ascribed thereto in this Article 1:
i. "Affiliate" shall mean with respect to a Party, any entity or person, that directly or indirectly though
one or more intermediaries, controls, is controlled by or is under common control with such Party.
The term "control" shall mean either the ownership, directly or indirectly, of (i) fifty percent (50%)
or more of the voting stock or equity shares or other ownership interest or with a right to elect the
majority of directors or equivalent governing body of such entity or person or (i) power to direct or
cause the direction of the management, policies or decisions of a entity or person whether through
Ownership of voting securities, control or otherwise.
11 Agreement" shall mean this Agreement and possible rrections or modifications thereater.
Page 2 ot 9
(NTAS)
CESTIA
VISTON
wThird Party" shall mean any person or entity other than: () IPL, (i) DR VASANTRAO PAWAR
V MEDICAL cOLLEGE, HOSPITAL & RESEARCH CENTER (BLOOD BANK) and (ii) their
respective Afiliates.
N o provision of this Agreement shall be interpreted adversely against a Party solely because that Party
was responsible for drafting that particular provision.
This Agreement has been drawn up in English. In the event of any discrepancy between the english
text of this Agreement [or any Agreement resulting there from or relating thereto] and any translation
thereof, the English language version shall prevail. The English language version shall also prevail for
interpretation purposes.
d The words "inchude", "included" or "including" are used to indicate that the matters listed are not a
complete enumeration of all listed items. Unless the context requires otherwise, words denoting the
shall include the plural and vice versa. Words denoting one gender shall include another
singularunless
gender, the context requires otherwise.
Criteria:
HOSPITAL & RESEARCH CENTER
i. DR VASANTRAO PAWAR MEDICAL COLLEGE,
for HIV I & II, HBsAg
(BLOOD BANK) shall be fully responsible for quality testing of plasma
HCV, Syphilis and Malaria. HOSPITAL & RESEARCH CENTER
ii. DR VASANTRAO PAWAR MEDICAL COLLEGE,
which is non-positive of aforesaid
(BLOOD BANK) shall supply only good quality plasma
diseases.
HOSPITAL & RESEARCH CENTER
ii. DR VASANTRAO PAWAR MEDICAL COLLEGE,
in hard and soft copy for all plasma supplied to IPL.
(BLOOD BANK) shall provide test results
HOSPITAL & RESEARCH CENTER
iv. DR VASANTRAO PAWAR MEDICAL COLLEGE,
bags in proper condition and at required
(BLOOD BANK) shall arrange to prOvide the plasma
temperature at blood bank.
COLLEGE, HOSPITAL & RESEARCH CENTER
V. DR VASANTRAO PAWAR MEDICAL
record of donors of all the plasma supplied to IPL for a
(BLOOD BANK shall maintain the
date of donation.
minimum of 5 (five) years from
period
the
3 OBLIGATIONS OF IPL:
EUTICA
Page 3 oft9
CELESTIAL
iVISl0N,
chall arrange for the pickup of
a) P wCE. HOSPITAL & RESEARCHplasma from DR
CENTER (BLOOD
VASANTRAO PAWAR MEDICAL
gon account of transportation of plasma shall be BANK) Freight and octroi expenses
ais stored and transported to the designated placesolely borne by IPL. IPL shall.ensure that the
Per the requisite guidelines. Once plasma is handed over under the required temperature as laid down
to IPL thereafter, the
transporting it in an appropriate/suitable condition shall solely lie on IPL. responsibility of
a Plasma volume calculation- The volume of plasma in each bag will be calculated
by the
formula- Volume of plasma in bag= (weight of filled plasma bag-weight of empty plasma following
bag)/ 1.023,
(where 1.023 is specific gravity of plasma)
b)Supply of FFP should be within 6 (six) months from the date of collection.
a) In lieu of the plasma supplied to PL, the IPL shall pay the notional cost of plasma as follows:
b) The mode of payment shall be in the form of "RTGS" or "at par cheque" which shalil be paid within
21 (Twenty one) days from the date of plasma pick-up by IPL.
6 CONFIDENTIALITY:
IPL and DR VASANTRAO PAWAR MEDICAL CO:LEGE, HOSPITAL & RESEARCH
(a) CENTER ( BLOOD BANK) shall maintain utmost secrecy of all IPs, data, particulars methods,
formulas, details, drawings and other confidential proprietary information (Confidential
of the Term.
Information) of other Party during and after the completion
This Confidential Information shall be utilized by the Parties for the purpose of this Agreement only
(b)
communicated to any Third Party without prior written
and same shall not be divulged, disclosed or
PAWAR MEDICAL COLLEGE, HOSPITAL &
permission of IPL or DR VASANTRAO
of such Confidential Information, as
RESEARCH CENTER ( BLOOD BANK) as the proprietors
the case may be.
Page 4 of9
CELESTIAL
IVISICN,
de
iii. Ts
independently developed by
receiving Party without
Information disclosed by the disclosing Party.
use or reference to the Confidential
Is disclosed to a Party by Third
iv. Party who
obligation towards the other Party
to the best of such
Party's knowledge is without any
77 TERM& TERMINATION:
8 NON EXCLUSIVITY:
Notwithstanding anything to the contrary elsewhere in the Agreement, the Parties hereby agree and
acknowledge that this is a non-exclusive arrangement and that this arangement does not in ay way
restricts any Party from entering into similar arrangements with third parties.
requirements in force.
d) It has all requisite power and authority to execute, deliver and perform this Agreement and the
terms and conditions contained herein., and each of its obligations are enforceable against it in
accordance with the terms of this Agreement.
does not in any way conflict or
e) The execution, delivery and performance of this Agrecment
other contract applicable to such
violate any provision of law, rule, judgment, order or any
Party. which
I)It has no commitments, liabilities or obligations, contractual or otherwise,
outstanding
to ènter into this
would in any material respect conflict with or impede its ability and right
Page 5 of9
INTA
CELESTIAL
de
ement or fulfill any and all of its
contemplated hereby. obligations hereunder, or to conduct the business
e is not subject to any
existing,
old have a material adverse effect
pending or threatened litigation or other
on its ability to fulfill its proceeding which
terms of this Agreement. undertakings and obligations in
ot hereby represents and warrants to DR
1 VASANTRAO PAWAR MEDICAL
HOSPITAL & RESEARCH CENTER ( BLOOD
BANK) that: COLLEGE,
c)It has all requisite power and authority to execute, deliver and
conditions contained herein., and each of its
terms and perform this Agreement and the
accordance with the terms of this Agreement obligations are enforceable
against it in
d) The execution, delivery and performance of this
violate any provision of law, rule,
Agreement does not in any way conflict or
judgment, order or any other contract applicable to such
Party.
e) It has no outstanding commitments, liabilities or
would in any material respect conflict with or
obligations, contractual or otherwise, which
impede its ability and right to enter into this
Agreement or fulfill any and all of its obligations hereunder, or to conduct the business
contemplated hereby.
) I t is not subject to any existing, pending or threatened litigation or other proceeding which
could have a material adverse effect on its ability to fulfill its undertakings and obligations in
terms of this Agreement.
a) any breach of any terms and conditions of this Agreenent, warranties and covenants;
c)Failure of the plasma to comply with the criteria and quality as provided in clause 2 (a) of
this Agreement;
b) negligence.
Page 6 of 9
NTAS
FORCE MAJEURE
10
f any provision
of this Agreement or the application thereof to any person or circumstance shall be
invalid or unenforceable to any extent, the remainder of this Agreement and the application of sueh
provision to persons or circumstances other than those as to which it is held invalid or unenforceable,
shall be valid and enforceable to the fullest extent permitted by law. Any invalid or unenforceable
provision of this Agreement shall be replaced with a provision which is valid and enforceable and most
hearly reflects the original intent of the unenforeeable provision.
14 ASSIGNMENT:
Neither Party will assign or transfer any rights or obligations under this Agreement without the prior
writtenconsent of the other Party, except that a Party may assign this Agreement without such consent
to
successor in interest by way of merger, acquisition or sale of all or substantially all its assets.
its of
Subject to the foregoing, this Agreement shall inure to the benefits of and be binding upon the successors
and permitted assigns of the Parties.
15
SURVIVAL:
which by its very nature should survive the expiry and termination ofthis Agreement shall
ses
Survive such termination or expiry
Page 7 of 9
NTAS
TSTTA
ON
16 IP:
RELATIONSHIP
20 NOTICES:
Any notice required to be given hereunder shall be in writing and shall be effectively served (i) if
delivered personally, upon receipt by the other Party: (i) if sent by prepaid courier service, airmail or
or other similar means of
gistered mail, within five (5) days of being sent; or (ii) if sent by facsimile notice by the sender.
cctronic communication (with confirmed receipt), upon receipt of transmission
y notice required to be given hereunder shall be sent to the addresses referred below
If to IPL
Near Sola Bridge, Ahmedabad-
Address: Corporate House, S.G. Highway, Thaltej,
380054, Gujarat, India,
Attention: LEGAL HEAD
Contact No: +91 79 26578862
Center (Blood Bank)
t to Dr Vasantrao Pawar College, Hospital & Research
Medical
Nashik -422207
Vasantdadanagar, Adgaon,
Address: Mumbai-Agra National Hwy,
Maharashtra .India,
Attention: LEGAL HEAD
Contact No.: 072322 43504
Page 8 of 9
(INTAS
H
1f not use the brand name,
Either Party shal
1ogo,
tsoever, without a priorwritten approval from mark or any
the other other intellectual
Party. property in any manner
Party shall
make or permit any person to make any
Neither
thout the prior written consent of the public announcement concerning this
22 Agreement withc
other Party
ed in two counterparts, each of
be signed
eement may
his which when signed and dated shall
23 stitute an original
of this Agreement but all the counterparts shall together constitute the same
A g r e e m e n t
Pharmaceuticals
Ltd. For. Dr Vasantrao Pawar Medical College, Hospital &
Intas Research Center (Blood Bank)
For.
ARMA
a/(iATAS
CELESTIA1.
DIVISIGH
AH EDA
Witness:
Witness:
HIHE
C w
(Hitesh Anjara)